D. Roychowdhury

发表

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

M. Casey, S. Stein, C. Geyer, 2008, Breast Cancer Research and Treatment.

Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer.

Nasser Altorki, A. Reeves, D. Yankelevitz, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antisense therapy directed to protein kinase C-alpha (Affinitak, LY900003/ISIS 3521): potential role in breast cancer.

D. Roychowdhury, M. Lahn, 2003, Seminars in oncology.

Preoperative treatment with pazopanib (GW786034), a multikinase angiogenesis inhibitor in early-stage non-small cell lung cancer (NSCLC): A proof-of-concept phase II study

D. Yankelevitz, N. Altorki, H. Pass, 2008 .

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER 2-Positive Breast Cancer

R. Greil, E. Winer, Minetta C. Liu, 2009 .

Early treatment with inhaled GM-CSF improves oxygenation and anti-viral immunity in COVID-19 induced lung injury – a randomized clinical trial

A. Sette, S. Dupont, R. Seurinck, 2021 .

Paclitaxel (3-hour infusion) followed by carboplatin (24 hours after paclitaxel): a phase II study in advanced non-small cell lung cancer.

D. Roychowdhury, P. Desai, Y. -. Zhu, 1997, Seminars in oncology.

A Report on Serious Pulmonary Toxicity Associated with Gemcitabine-Based Therapy

M. Arning, D. Roychowdhury, P. Peterson, 2002, Investigational New Drugs.

Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.

T. Yamanaka, M. Ahn, Yi-long Wu, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

C. Sternberg, C. Barrios, I. Davis, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.

P. Albers, M. Moore, I. Bodrogi, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.

L. Seymour, M. Moore, W. Stadler, 2002, Urologic oncology.

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

A. Sette, S. Dupont, R. Seurinck, 2022, Cell Reports Medicine.

Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group.

J. Crowley, K. Kelly, P. Bunn, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model

S. Authier, D. Roychowdhury, Yifei Zhong, 2020, International journal of radiation biology.

Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm)

D. Roychowdhury, R. Paine, E. Halstead, 2022, Military medicine.

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

J. Bussel, M. Arning, B. Psaila, 2009, The Lancet.

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

R. Greil, E. Winer, Minetta C. Liu, 2009, Clinical Cancer Research.

Multilobated Large B-Cell Lymphoma Diagnosed Cytologically

D. Roychowdhury, R. Yassin, P. Steele, 1999, Acta Cytologica.

Eff ect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura : a randomised , double-blind , placebo-controlled trial

J. Bussel, M. Arning, B. Psaila, 2009 .

D. Roychowdhury, A. Liepa, A. Hayden, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence of thrombocytopenia with gemcitabine-based therapy and influence of dosing and schedule

D. Roychowdhury, L. Cirera, P. Peterson, 2001, Anti-cancer drugs.

Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.

D. Roychowdhury, C. Linker, 1995, Bone marrow transplantation.

The value of label recommendations: how to dose lapatinib.

D. Roychowdhury, K. Koch, A. Beelen, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New prognostic factors in nasopharyngeal carcinoma: Tumor angiogenesis and C‐erbB2 expression

K. Fu, N. Weidner, D. Roychowdhury, 1996, Cancer.

D. Roychowdhury, A. Hayden, 2003 .

Results of an analysis of cardiac function in 2,812 patients treated with lapatinib.

M. Berger, S. Stein, T. Zaks, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Boosting Abscopal Response to Radiotherapy with Sargramostim: A Review of Data and Ongoing Studies

D. Roychowdhury, C. Mockbee, R. Leary, 2019, Cureus.

INTO DRUG DEVELOPMENT: AN INDUSTRY PERSPECTIVE

D. Roychowdhury, P. Murphy, 2008 .

1 INCORPORATING IMAGING INTO DRUG DEVELOPMENT : AN INDUSTRY PERSPECTIVE

D. Roychowdhury, P. Murphy, 2008 .

Phase II study of crizotinib in east Asian patients (pts) with ROS1-positive advanced non-small cell lung cancer (NSCLC).

T. Yamanaka, M. Ahn, Yi-long Wu, 2016 .

A Phase II Study of Sequential Neoadjuvant Gemcitabine and Paclitaxel, Radiation Therapy With Cisplatin and 5-Fluorouracil and Surgery in Locally Advanced Esophageal Carcinoma

J. Howington, A. Lowy, Syed A. Ahmad, 2006, American journal of clinical oncology.

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

J. Bussel, M. Arning, B. Psaila, 2009, The Lancet.